MENU

Aggregating and Sharing Clinical Evidence to Improve the Diagnosis of Rare Diseases

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Co-Founder and Managing Director, Limbus Medical Technologies
    Biography
      Dr. Ben Liesfeld is Co-Founder and Managing Director of Limbus Medical Technologies, a medical software company whose mission is to support and facilitate genetic diagnostics. A physicist by training, he co-invented computer guided laser surgery devices for ophthalmology. When accepting a position in a clinical laboratory in 2013 he learned about the huge potential and the challenges of diagnosing rare diseases using next-generation sequencing. This led him to create an independent enterprise to leverage software and real-world evidence in order to solve the puzzles of genetic diseases.

    Abstract

    The introduction of improved, more cost efficient target capture technologies has accelerated the adoption of Whole Exome Sequencing (WES) in clinical diagnostics. The ability to provide more complete answers to patients with rare diseases in turn has increased the interest of physicians in genetic testing. Clinical genetic testing today is generating more real world evidence than any large scale research sequencing project has or will ever have. However, this valuable real world evidence remains underutilized due to the lack of proper technology and due to legal obstacles. In practice WES generates large amounts of information that need to be processed and interpreted. If used in routine diagnostics, the data processing and the interpretation must be standardized, clinically validated and ultimately automated to a high degree. The hands-on time of creating a diagnosis must be a matter of minutes and not of days or weeks. Taking together the genotype and phenotype information from a large number of patients can improve the success rate in diagnostic testing significantly. Healthcare institutions address these challenges to a variable degree by creating and maintaining proprietary in-house software or by using a patchwork of third-party solutions. A single, streamlined solution for these challenges is varvis, a diagnostic software that covers the entire workflow from raw data to interpretation and reporting. Using varvis, diagnostic laboratories across Europe, Canada and the USA are aggregating and sharing real-world evidence and improving patient care in compliance with data privacy regulations. The aggregated database now contains information about 19,000,000 unique variants from 35,000 cases. I will present case examples how patients benefit from this knowledgebase and how it enables clinical labs to quickly scale up WES diagnostics.

    Learning Objectives:

    1. How Whole Exome Sequencing has matured to become a first-line diagnostic method in clinical genetics and what its benefit is for the patient

    2. Which tools and processes are necessary to successfully deploy this powerful method in routine diagnostics at scale

    3. How every data point from every single patient can be leveraged to continuously improve the quality and success of the diagnostic process.


    Show Resources
    You May Also Like
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    NOV 10, 2020 7:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    Loading Comments...
    Show Resources